Department of Otorhinolaryngology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan.
Department of Otorhinolaryngology, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka 589-8511, Japan.
Auris Nasus Larynx. 2023 Feb;50(1):165-168. doi: 10.1016/j.anl.2021.12.007. Epub 2021 Dec 18.
Coronavirus disease 2019 (COVID-19) occasionally causes acute laryngitis, requiring emergency treatment. Understanding the characteristic laryngeal findings can help diagnose COVID-19 earlier, prevent worsening infection, and properly manage airway obstruction. Herein, we report the case of a 44-year-old male with acute epiglottitis likely caused by COVID-19. On presentation, chest computed tomography (CT) showed no signs of pneumonia. However, the larynx had extensive necrotic-like erosive lesions resembling those of tuberculous laryngitis. COVID-19 was diagnosed by reverse-transcription polymerase chain reaction, and secondary bacterial superinfections were suspected after blood testing. The symptoms improved after administration of antibiotics (sulbactam sodium/ampicillin sodium), steroids (dexamethasone), and favipiravir. The patient developed a high fever on the sixth day of hospitalization, and pneumonia was identified on CT. Various culture tests, including tuberculosis, were negative. Thus, remdesivir was administered for COVID-19-induced pneumonia. The patient gradually recovered, was transferred to another hospital, and was discharged on the 35th day of hospitalization. Six previous case reports of COVID-19-induced acute epiglottitis suggested that acute epiglottitis preceded the onset of pneumonia. The laryngeal findings from this report may be useful for diagnosing COVID-19 that does not cause pneumonia and for bringing attention to pneumonia after a COVID-19 diagnosis.
新型冠状病毒病(COVID-19)偶尔会引起急性喉炎,需要紧急治疗。了解特征性的喉部表现有助于更早诊断 COVID-19,防止感染恶化,并妥善处理气道阻塞。在此,我们报告了一例由 COVID-19 引起的急性会厌炎的 44 岁男性病例。就诊时,胸部计算机断层扫描(CT)未显示肺炎迹象。然而,喉部有广泛的类似结核性喉炎的坏死样糜烂性病变。通过逆转录聚合酶链反应诊断为 COVID-19,血液检查后怀疑继发细菌感染。给予抗生素(舒巴坦钠/氨苄西林钠)、类固醇(地塞米松)和法匹拉韦治疗后症状改善。患者在住院第六天出现高热,CT 显示肺炎。各种培养试验,包括结核病,均为阴性。因此,给予瑞德西韦治疗 COVID-19 引起的肺炎。患者逐渐康复,转至另一家医院,住院 35 天后出院。之前有 6 例 COVID-19 引起的急性会厌炎的病例报告表明,急性会厌炎先于肺炎发生。本报告中的喉部表现可能有助于诊断不引起肺炎的 COVID-19,并引起对 COVID-19 诊断后肺炎的关注。